title: Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
authors.forename: Michele
authors.initials: M
authors.lastname: Milella
authors.forename: Diana
authors.initials: D
authors.lastname: Giannarelli
authors.forename: Virginia
authors.initials: V
authors.lastname: Ferraresi
authors.forename: Marcella
authors.initials: M
authors.lastname: Mottolese
authors.forename: Claudio
authors.initials: C
authors.lastname: Botti
authors.forename: Cecilia
authors.initials: C
authors.lastname: Nisticò
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005260:Female; D005498:Follicular Phase; D006801:Humans; D008183:Luteal Phase; D008408:Mastectomy / Q000379:methods*; D008597:Menstrual Cycle; D008875:Middle Aged; D010052:Ovariectomy / Q000379:methods*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000378:metabolism*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen